These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 15864228)

  • 1. Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study of pexelizumab in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Armstrong PW; Adams PX; Al-Khalidi HR; Hamm C; Holmes D; O'Neill W; Todaro TG; Vahanian A; Van de Werf F; Granger CB;
    Am Heart J; 2005 Mar; 149(3):402-7. PubMed ID: 15864228
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiogenic shock and heart failure post-percutaneous coronary intervention in ST-elevation myocardial infarction: observations from "Assessment of Pexelizumab in Acute Myocardial Infarction".
    French JK; Armstrong PW; Cohen E; Kleiman NS; O'Connor CM; Hellkamp AS; Stebbins A; Holmes DR; Hochman JS; Granger CB; Mahaffey KW
    Am Heart J; 2011 Jul; 162(1):89-97. PubMed ID: 21742094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-segment recovery and outcome after primary percutaneous coronary intervention for ST-elevation myocardial infarction: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Buller CE; Fu Y; Mahaffey KW; Todaro TG; Adams P; Westerhout CM; White HD; van 't Hof AW; Van de Werf FJ; Wagner GS; Granger CB; Armstrong PW
    Circulation; 2008 Sep; 118(13):1335-46. PubMed ID: 18779444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized, double-blind, placebo-controlled study of the safety and efficacy of intravenous MCC-135 as an adjunct to primary percutaneous coronary intervention in patients with acute myocardial infarction: Evaluation of MCC-135 for left ventricular salvage in acute myocardial infarction (EVOLVE).
    Jang IK; Weissman NJ; Picard MH; Zile MR; Pettigrew V; Shen S; Tatsuno J; Hibberd MG; Tzivoni D; Wackers FJ;
    Am Heart J; 2008 Jan; 155(1):113.e1-8. PubMed ID: 18082500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial.
    ; Armstrong PW; Granger CB; Adams PX; Hamm C; Holmes D; O'Neill WW; Todaro TG; Vahanian A; Van de Werf F
    JAMA; 2007 Jan; 297(1):43-51. PubMed ID: 17200474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unicenter, randomized, double-blind, parallel-group, placebo-controlled study of Melatonin as an Adjunct in patients with acute myocaRdial Infarction undergoing primary Angioplasty The Melatonin Adjunct in the acute myocaRdial Infarction treated with Angioplasty (MARIA) trial: study design and rationale.
    Dominguez-Rodriguez A; Abreu-Gonzalez P; Garcia-Gonzalez MJ; Kaski JC; Reiter RJ; Jimenez-Sosa A
    Contemp Clin Trials; 2007 Jul; 28(4):532-9. PubMed ID: 17123867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategic lessons from the clinical event classification process for the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Mahaffey KW; Wampole JL; Stebbins A; Berdan LG; McAfee D; Rorick TL; French JK; Kleiman NS; O'Connor CM; Cohen EA; Granger CB; Armstrong PW;
    Contemp Clin Trials; 2011 Mar; 32(2):178-87. PubMed ID: 21220052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of complement activation by pexelizumab reduces death in patients undergoing combined aortic valve replacement and coronary artery bypass surgery.
    Carrier M; Ménasché P; Levy JH; Newman MF; Taylor KM; Haverich A; Chen JC; Shernan SK; Van de Werf F; van der Laan M; Todaro TG; Adams PX; Verrier ED
    J Thorac Cardiovasc Surg; 2006 Feb; 131(2):352-6. PubMed ID: 16434264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized evaluation of intracoronary nitroprusside vs. adenosine after thrombus aspiration during primary percutaneous coronary intervention for the prevention of no-reflow in acute myocardial infarction: the REOPEN-AMI study protocol.
    Niccoli G; D'amario D; Spaziani C; Cosentino N; Marino M; Rigattieri S; Schiavo PL; De Vita MR; Tarantino F; Bartorelli A; Fabbiocchi F; Prati F; Imola F; Valgimigli M; Ferrari R; Crea F
    J Cardiovasc Med (Hagerstown); 2009 Jul; 10(7):585-92. PubMed ID: 19384242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pexelizumab fails to inhibit assembly of the terminal complement complex in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Insight from a substudy of the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) trial.
    Martel C; Granger CB; Ghitescu M; Stebbins A; Fortier A; Armstrong PW; Bonnefoy A; Theroux P
    Am Heart J; 2012 Jul; 164(1):43-51. PubMed ID: 22795281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Letter of comment on "Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial" (Am Heart J 2006;152:887.e9-14).
    Vydt T; Agostoni P
    Am Heart J; 2007 May; 153(5):e25; author reply e27. PubMed ID: 17452140
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Dudek D; Sardella G; Marino P; Chevalier B; Zijlstra F
    Eur Heart J; 2008 Dec; 29(24):3002-10. PubMed ID: 18775918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.
    Toma M; Buller CE; Westerhout CM; Fu Y; O'Neill WW; Holmes DR; Hamm CW; Granger CB; Armstrong PW;
    Eur Heart J; 2010 Jul; 31(14):1701-7. PubMed ID: 20530505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials.
    De Luca G; Biondi-Zoccai G; Marino P
    Ann Emerg Med; 2008 Dec; 52(6):665-76. PubMed ID: 19027496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracoronary infusion of autologous mononuclear bone marrow cells or peripheral mononuclear blood cells after primary percutaneous coronary intervention: rationale and design of the HEBE trial--a prospective, multicenter, randomized trial.
    Hirsch A; Nijveldt R; van der Vleuten PA; Biemond BJ; Doevendans PA; van Rossum AC; Tijssen JG; Zijlstra F; Piek JJ;
    Am Heart J; 2006 Sep; 152(3):434-41. PubMed ID: 16923409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of six-month outcomes for primary percutaneous revascularization for acute myocardial infarction with drug-eluting versus bare metal stents (from the APEX-AMI study).
    Patel MR; Pfisterer ME; Betriu A; Widmisky P; Holmes DR; O'Neill WW; Stebbins A; Van de Werf F; Armstrong PW; Granger CB;
    Am J Cardiol; 2009 Jan; 103(2):181-6. PubMed ID: 19121433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pexelizumab in coronary artery bypass graft surgery with extended aortic cross-clamp time.
    Smith PK; Carrier M; Chen JC; Haverich A; Levy JH; Menasché P; Shernan SK; Van de Werf F; Adams PX; Todaro TG; Verrier E
    Ann Thorac Surg; 2006 Sep; 82(3):781-8; discussion 788-9. PubMed ID: 16928483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracoronary nitroprusside for the prevention of the no-reflow phenomenon after primary percutaneous coronary intervention in acute myocardial infarction. A randomized, double-blind, placebo-controlled clinical trial.
    Amit G; Cafri C; Yaroslavtsev S; Fuchs S; Paltiel O; Abu-Ful A; Weinstein JM; Wolak A; Ilia R; Zahger D
    Am Heart J; 2006 Nov; 152(5):887.e9-14. PubMed ID: 17070151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prophylactic intraaortic balloon pumping preserves left ventricular systolic function in acute anterior myocardial infarction without cardiogenic shock].
    Niida T; Sakuma T; Motoda C; Tokuyama T; Oka T; Okada T; Otsuka M; Toyofuku M; Hirao H; Muraoka Y; Ueda H; Masaoka Y; Hayashi Y
    J Cardiol; 2006 Nov; 48(5):243-51. PubMed ID: 17136819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II).
    Ross AM; Gibbons RJ; Stone GW; Kloner RA; Alexander RW;
    J Am Coll Cardiol; 2005 Jun; 45(11):1775-80. PubMed ID: 15936605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.